CompoAtlas

Calcium 167 mg Tablets

Natural health product licensed in Canada

Licence holder
BIOVANTEK
NPN or DIN-HM
80069059
Status
Inactive licence
Licence date
2 May 2016
Revision date
18 May 2022
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Calcium

Source : Carbonate de calcium

167 milligrammeNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Maltodextrine, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adolescentesminimum: 9 years ; maximum: 13 years1 Compriméminimum: 1 Tous les jours ; maximum: 2 Tous les jours
Enfantsminimum: 3 years ; maximum: 6 years1 Compriméminimum: 1 Tous les jours ; maximum: 2 Tous les jours
Adultes et adolescentsminimum: 13 years1 Compriméminimum: 1 Tous les jours ; maximum: 2 Tous les jours
Enfantsminimum: 1 year ; maximum: 3 years1 Compriméminimum: 1 Tous les jours ; maximum: 2 Tous les jours
Enfantsminimum: 4 years ; maximum: 9 years1 Compriméminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

Helps in the development and maintenance of bones and teeth (especially in childhood, adolescence and young adulthood). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Source of/An electrolyte for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80069059

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line